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HZ: Tell me about yourself  and your professional 
background?
MC: I grew up in Edinburgh, in Scotland and studied 
Medicine at Manchester University. I chose Medicine because 
I wanted to become a forensic pathologist; maybe I had read 
too many crime novels! I soon became more interested in 
infectious diseases, and after completing internships in 
infectious diseases and pathology, I was keen to work  abroad 
in settings where infectious diseases remain important. It 
was during my Diploma in Tropical Medicine and Hygiene 
at the Liverpool School of  Tropical Medicine that I became 
passionate about public health and epidemiology. Inspired 
by this experience, I went on to complete a public health 
clinical training scheme in southeast London, and soon after, 
I joined the Karonga Prevention Study (KPS) in Malawi. 
I arrived in Malawi in 1998 as a field epidemiologist and 
now I am Professor of  Epidemiology at London School of  
Hygiene and Tropical Medicine, and Professor of  Global 
Health Epidemiology at University of  Glasgow. Just like me, 
KPS has changed and developed over the years and is now 
known as Malawi Epidemiology and Intervention Research 
Unit (MEIRU) and is established as an NGO; a partnership 
between Malawi Ministry of  Health, Malawi College of  
Medicine, London School of  Hygiene and Tropical Medicine, 
and University of  Glasgow. 
HZ: You have mentioned of  your passion in infectious 
diseases, why did you want to work overseas? What 
motivated you then?
MC: In the UK, much of  clinical medicine is centered on 
management of  chronic conditions in elderly people that 
are associated with lifestyle; diabetes, chronic pulmonary 
disease, heart disease and so on. But in my early career I 
was fascinated by infectious disease. As a medical student in 
the 1980s, when the HIV epidemic was emerging, I decided 
to do my medical elective in HIV in New York, where 
they were at the forefront of  HIV management. I was also 
interested in tropical infections, so a move to Malawi, where 
infectious diseases were much a bigger part of  the problem, 
was a natural progression. And now, some twenty years later, 
I have come full circle, spending much of  my time thinking 
about chronic conditions in Malawi. 
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HZ: Tell me a about brief  history of  the Karonga 
Prevention Study (KPS)?
MC: KPS started in 1979 with Professor Paul Fine and Dr 
Jorg Ponnighaus. Initially established as a study of  Leprosy 
with support from the British Leprosy Relief  Association. 
When I joined in 1998, we worked mostly on vaccine trials 
and epidemiological studies in TB and HIV with additional 
studies in the genetics and immunology of  TB and leprosy. 
We established a demographic surveillance site in Karonga 
in 2002, which is still operating and is very highly regarded. 
We had a program of  pneumococcal related work with 
Professor Neil French, and then we continued looking at 
the impact of  the new ART programs. What become very 
clear by the late 2000’s from our verbal autopsy work in 
Karonga, was that the decline in mortality rate in adults 
from HIV was revealing an underlying very high mortality 
of  non-communicable diseases. In 2012 we received funding 
from Wellcome Trust, to establish large studies of  chronic 
conditions. Working with the Ministry of  Health we selected 
Area 25 in Lilongwe to establish our urban population 
research platform and the Community Health Sciences Unit 
(CHSU), for our urban headquarters. Between 2013 and 
2016 we conducted a rural and urban study, recruiting 33,000 
adults with collection of  detailed information on NCD risk 
factors and health outcomes. Large epidemiological studies 
of  this kind are necessary to understand who is the most 
affected in the population, what the determinants are of  their 
conditions and later, the incidence of  disease and ultimately 
health trajectories and survival. Particularly when you are 
looking at chronic conditions or even the infectious diseases 
which manifest over many years like Tuberculosis, HIV and 
so on, it is very important to be able to track people reliably 
over many years. We have people in Karonga whom we first 
saw in 1979, and we continue to be in contact with them, 
which enables us to do incredibly important studies on the 
development of  disease over the life-course. 
HZ: As you said, you came in as a field epidemiologist 
in Karonga in 1998 but now you are the Director of  
MEIRU, what are your responsibilities as a Director? 
MC: My current role is multifaceted. I develop and maintain 
external partnerships and collaborations that are essential to 
the pursuit of  strategic, high quality research. On a day-to-
day I ensure that policy makers are informed of  the work we 
do -whether at national, regional or international level, – by 
creating visibility through interfacing with our policy makers 
and partners. 
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I am also responsible for securing substantive research 
grants to support the work that we do here and I also 
provide mentorship to our research team to ensure that 
they experience career development. I have the ultimate 
responsibility for the conduct of  all studies. This includes 
ensuring that our studies are conducted ethically, that high 
quality data are collected, and that those data are turned 
into policy relevant findings.  As Director, I also lead the 
senior management team, which means that I have oversight 
of  all kind of  administrative functions, in addition to the 
research. Fortunately I am supported by a strong team and 
the MEIRU trustees.  
HZ: What has been the impact of  MEIRU’s research 
projects in Malawi so far and how have the findings 
informed clinical practice?
MC: The impact of  epidemiological research studies are not 
always easy to identify as they tend to influence policy rather 
than clinical practice. For example, in the case of  NCDs, we 
are fortunate in Malawi that the NCD Department at the 
Ministry of  Health are very responsive. As such our findings 
on hypertension and diabetes have informed the Ministry’s 
approach by highlighting that these are not urban conditions 
only but also significantly impacting on the rural poor. That 
is very important in terms of  understanding how services 
must be delivered and made available throughout health 
sector in Malawi. 
Having said that, we have moved rapidly from collecting 
observational data to intervention trials to tackle these 
problems. We have multiple intervention trials in progress, 
including a study together with the Ministry of  Health 
and Education whereby we are developing a large cluster 
randomized trial of  sodium reduction through a curriculum 
intervention in schools. It’s a very scalable intervention 
and trials in China have shown reduced sodium intake and 
hypertension in whole communities using a similar approach. 
HZ: What future plans and possibilities in the field of  
research are there for Malawi?
MC: Malawi is finding itself  increasingly in a situation 
where people have multiple chronic conditions (for example 
HIV, hypertension, diabetes, chronic lung disease, epilepsy 
to name a few). The extent to which these conditions are 
influenced by early life exposures is not well understood but 
early life influences are likely to be important. Research in 
this area will help us to understand better how to manage 
and ideally to mitigate the consequences.  
There are a combination of  factors like poor nutrition in 
pregnancy and infancy, repeated exposure to infectious 
diseases, environmental exposures and stress that build up 
a burden of  chronic conditions. At present we are planning 
a large chronic conditions cohort that will, pending funding 
support, explore all of  these issues so that we can understand 
the origins of  these diseases at very early life and how to 
prevent them.  
HZ: As someone who has worked with MEIRU for 
quite a very long time, are there challenges you have 
met in your work?
MC: As a small research organization, one of  our main 
challenges is that we don’t have the benefit of  core funding 
that large institutions receive. This means that we need to 
work very hard to secure grants to sustain not only our 
research projects but also our research infrastructure. As 
small can be beautiful, there is a good argument for being 
modestly sized and focusing on excellence rather than 
growth. 
Supporting young Malawian researchers throughout their 
careers is also challenging but we are proud that many of  
our staff  go on to develop successful careers in other good 
institutions. Malawi has a growing cadre of  impressive 
researchers and ideally in 10 to 20 years’ time, senior 
Malawian researchers will lead all of  the research affiliates. 
We were lucky enough to have Professor. Moffat Nyirenda 
as our director for few years before he took up his post in 
Uganda. 
HZ: You are also the leader of  African Non-
communicable Disease Longitudinal data Alliance 
(ANDLA), what is it like to lead this consortium?
MC: I can honestly say ANDLA is a partnership rather than 
an organization with a leader. I applied for the money to 
establish it, but it is a network of  seven different partner 
institutions in Africa. One in Kenya, one in Uganda, one 
in Malawi, two in Tanzania, two in South Africa, all very 
well-known institutions. We harmonize longitudinal data 
on chronic conditions and at the moment we are looking 
at cardiovascular risk scores, and how to validate them for 
African populations. Most of  us have been working together 
for a long time on HIV data so we know each other very well 
and have the trust to share datasets. 
HZ: What outstanding life experiences or achievements 
are you proudest of ?
MC: I am very proud of  MEIRU and our approach to 
longitudinal studies and I think it does give a sense of  pride 
when that’s recognized as one of  most rigorously collected 
and best datasets for answering particular questions from the 
region. That takes a lot of  persistence!
HZ: You have spent quite a lot of  time in Malawi, from 
1998 up to date, is there something in particular that 
you like in Malawi. 
MC: It’s no secret that I loved living in Chilumba, and for me 
it was the perfect place to raise a family. My daughters grew 
up running around outside with their friends and had lot of  
freedom. Maybe because I am Scottish I felt very at home 
between the mountains and the lake, and when I moved from 
London to Malawi I felt I had come home because of  the 
friendliness I also recognized from growing up in Scotland. 
HZ: Thank you so much for your time and insights into 
your professional and personal life. Do you have any 
last words?
MC: In addressing chronic conditions it is going to be 
very important to have multi-sectoral actions; involving 
agricultural, involving town-planning and involving industry 
to improve people’s health and wellbeing. Health researchers 
will need to become much more expert in fostering these 
collaborations for the benefit of  public health. That is the 
challenge for MEIRU over the next few years. 
